The Latest Breaking News from FDA

The former president is reviving campaign promises to undo Obamacare, an idea that fizzled during his first time in office. Based on his record, here's what else he might do in health policy.

The points about marijuana's risks and benefits that the department now concedes were clear long before last August.

The pharmaceutical sector is anticipated to prosper due to the strong demand for drugs and therapies and the adoption of advanced technologies. So, let’s analyze whether pharmaceutical stocks Kamada (KMDA), Neurocrine Biosciences (NBIX), and Novartis (NVS) are well positioned to capitalize on the industry’s growth prospects.

Learn about the recent recall of ResMed's respiratory devices by the US FDA, deemed as the most serious. Find out more about the implications and what acti...

The FDA states that popular drugs for diabetes and obesity do not appear to be linked to suicidal thoughts but continues to investigate reports.

Federal officials say a preliminary review finds no connection between suicidal thoughts and a new class of diabetes and obesity drugs

People with obstructive sleep apnea symptoms can now get a diagnosis and treatment much sooner, thanks to a pioneering sleep apnea detection device.

A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.